Track topics on Twitter Track topics that are important to you
The company will present data from Cohort 1 of its ongoing Phase 2/3 clinical trial of INOpulse in San Antonio, Texas.
The post Bellerophon Presents Data of Ongoing Phase 2/3 Study of INOpulse appeared first on Investing News Network.
Original Article: Bellerophon Presents Data of Ongoing Phase 2/3 Study of INOpulseNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...